Chris Dennis to join Angiotech Pharmaceuticals as Senior Vice President, Sales and Marketing
Life Science Partner announces recruitment of former Global President of J&J’s OrthoNeutrogena Company, a Division of Ortho-McNeil Pharmaceutical, Inc.
Life Science Partner announces the appointment of Chris Dennis, a senior sales, marketing and general management executive, to Angiotech Pharmaceuticals, Inc. as the Senior VP of Sales and Marketing. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.
In Dennis’ most recent role at OrthoNeutrogena, a pharmaceutical and aesthetic device company, he was responsible for the overall strategy and business growth initiatives. In his previous position at Janssen Ortho, Inc., a Canadian pharmaceutical company, he served as Vice President of Marketing and Sales where he managed a wide range of prescription medications. Mr. Dennis also held the position of President, LifeScan Canada Ltd. (medical devices), where he oversaw the sales, marketing and distribution of diagnostic products for people with diabetes. He also held a number of sales and management roles at McNeil Consumer Products, a J&J company, and Bristol Myers Products Canada.
At Angiotech, Dennis will be focused on building a global sales and marketing organization and commercialization strategy that includes the company’s sales and market capability in the five identified markets of Ophthalmology, Wound Closure, Vascular, Biopsy and Aesthetics. He will have the responsibility for building near-term strategies and subsequent revenues from innovating technologies existing within each of these product areas.
Leave a ReplyWant to join the discussion?
Feel free to contribute!